GlassScriptPhysician profile
Ronald D Gim
NPI 1316039753
$17,305.56
in general payments reported to CMS, 2019-2025
55 companies · $2,692 in 2025
The $2,692 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,825 · 2020: $1,388 · 2021: $2,577 · 2022: $3,000 · 2023: $2,636 · 2024: $2,188 · 2025: $2,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,516.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,707.33 | 2019-2025 | Orsiro Mission, Amvia Edge, Biomonitor |
| Novartis Pharmaceuticals Corporation | $1,409.23 | 2019-2025 | |
| Boston Scientific Corporation | $1,085.42 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Avvigo Guidance System, Rotapro |
| Amgen INC. | $824.16 | 2019-2025 | Repatha, Repatha |
| Inari Medical, INC. | $813.09 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $813.03 | 2019-2025 | Lifevest |
| Abbott Laboratories | $710.63 | 2019-2024 | Jot Dx, Navitor, Perclose Prostyle |
| Impulse Dynamics (USA) INC. | $698.64 | 2022-2023 | Optimizer |
| Aop Health US, LLC | $525.00 | 2025 | Rapiblyk |
| Boehringer Ingelheim Pharmaceuticals, INC. | $520.92 | 2020-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $460.46 | 2019-2024 | |
| Alnylam Pharmaceuticals INC. | $440.40 | 2022-2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $429.56 | 2021-2025 | Verquvo, Winrevair |
| E.R. Squibb & Sons, L.L.C. | $417.14 | 2019-2025 | Camzyos |
| Abiomed | $409.26 | 2020-2023 | Impella |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $379.15 | 2021-2025 | Micra, Attain Command + Surevalve, Linq II |
| Stryker Corporation | $372.71 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $361.90 | 2019-2025 | |
| Scpharmaceuticals INC. | $317.80 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $316.32 | 2019-2024 | Xarelto |
| Penumbra, INC. | $296.36 | 2019 | |
| Novo Nordisk INC | $290.88 | 2022-2025 | Wegovy, Ozempic |
| Chiesi USA, INC. | $255.50 | 2019-2025 | Kengreal |
| Cvrx, INC. | $252.00 | 2021-2025 | Barostim Neo System |
| Astellas Pharma US INC | $222.30 | 2019 | |
| Esperion Therapeutics, INC. | $205.43 | 2020-2023 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $181.80 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $132.98 | 2022-2025 | Assure Wcd |
| Cardiva Medical, INC. | $117.39 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Siemens Medical Solutions USA, INC. | $111.08 | 2023-2024 | Embozene |
| Atricure, INC. | $108.80 | 2024-2025 | Atriclip Laa Exclusion System |
| Kiniksa Pharmaceuticals, LTD. | $108.59 | 2021-2023 | Arcalyst |
| Infobionic, INC | $101.65 | 2025 | Mome Device |
| Cardiovascular Systems INC. | $95.33 | 2019-2021 | |
| Amarin Pharma, INC. | $79.16 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $76.65 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $75.40 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $72.57 | 2024-2025 | Uptravi, Opsumit |
| Tactile Systems Technology INC | $68.58 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $60.10 | 2020-2022 | |
| Medtronic Vascular, INC. | $44.90 | 2019-2020 | |
| Bardy Diagnostics, INC. | $37.33 | 2020-2021 | |
| Bridgebio Pharma, INC. | $34.94 | 2025 | Attruby |
| Philips North America LLC | $28.21 | 2024-2025 | (Bs2) Lm Undivided, Ice 3d |
| Cleerly, INC. | $27.82 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Gilead Sciences, INC. | $25.20 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $24.90 | 2019 | |
| Ani Pharmaceuticals, INC. | $24.13 | 2024 | Purified Cortrophin Gel |
| Astrazeneca Pharmaceuticals LP | $23.14 | 2024 | Wainua |
| Azurity Pharmaceuticals, INC. | $22.06 | 2023 | Edarbi |
| Altathera Pharmaceuticals LLC | $21.90 | 2025 | Sotalol Hydrochloride |
| Preventice Services, LLC | $20.72 | 2021 | |
| Glaxosmithkline, LLC. | $16.68 | 2025 | Shingrix, Arexvy |
| Lundbeck LLC | $15.36 | 2020 | |
| Itamar Medical INC | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Gim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.